BIOMAT Database Logo BIOMAT Database Logo

Liquid chromatographic method for the determination of debrisoquine and its 4-hydroxy metabolite in human urine. 1986

K Róna, and L Vereczkey, and B Gachályi

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry

Related Publications

K Róna, and L Vereczkey, and B Gachályi
Rapid liquid chromatographic determination of debrisoquine and its hydroxy metabolite in human urine to define hydroxylation phenotypes.
December 1987, Journal of chromatography,
K Róna, and L Vereczkey, and B Gachályi
Rapid high-performance liquid chromatographic method for determination of debrisoquine and 4-hydroxy-debrisoquine in urine for CYP2D6 phenotyping.
August 1999, Pharmacogenetics,
K Róna, and L Vereczkey, and B Gachályi
Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography.
January 1986, Journal of chromatography,
K Róna, and L Vereczkey, and B Gachályi
Comparison of gas chromatographic and high-performance liquid chromatographic assays for the determination of debrisoquine and its 4-hydroxy metabolite in human fluids.
March 1988, Journal of chromatography,
K Róna, and L Vereczkey, and B Gachályi
High-performance liquid chromatographic determination of ochratoxin A and its 4R-4-hydroxy metabolite in human urine.
February 1990, The Analyst,
K Róna, and L Vereczkey, and B Gachályi
High-performance liquid chromatographic method for the analysis of debrisoquine and its S-(+)- and R-(-)-hydroxy metabolites in urine.
December 1987, Journal of chromatography,
K Róna, and L Vereczkey, and B Gachályi
Improved selectivity of a high-performance liquid chromatography assay for debrisoquine and its 4-hydroxy metabolite from urine.
September 1990, Therapeutic drug monitoring,
K Róna, and L Vereczkey, and B Gachályi
Liquid chromatographic assay for debrisoquine and 4-hydroxydebrisoquine in urine.
January 1986, Journal of chromatography,
K Róna, and L Vereczkey, and B Gachályi
High-performance liquid chromatographic determination of proquazone and its m-hydroxy metabolite in spiked human plasma and urine.
January 2007, Journal of AOAC International,
K Róna, and L Vereczkey, and B Gachályi
High-performance liquid chromatographic method for the determination of diclofenac and its hydroxy metabolites in human plasma and urine.
June 1990, Journal of chromatography,
Copied contents to your clipboard!